Wilson's Disease Should Be Treated with Zinc rather than Trientine or Penicillamine

被引：6

作者：

Avan, Abolfazl ^{[1
,2
]}

de Bie, Rob M. A. ^{[2
]}

Hoogenraad, Tjaard U. ^{[3
]}

机构：

[1] Mashhad Univ Med Sci, Sch Med, Dept Neurol, Mashhad, Iran

[2] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands

[3] Univ Med Ctr, Dept Neurol, Utrecht, Netherlands

来源：

关键词：

ORAL ZINC; THERAPY;

D O I：

10.1055/s-0037-1603975

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：394 / 395

页数：2

共 17 条

[1] Avan A, 2013, MOVEMENT DISORD, V28, pS353
[2] Avan A, 2013, MOVEMENT DISORD, V28, pS352
[3] Ferenci P, 2012, J HEPATOL, V56, P671, DOI 10.1016/j.jhep.2011.11.007
[4] GRASEDYCK K, 1988, Z RHEUMATOL, V47, P17
[5] Hermann W, 2012, LEITLINIENFURDIAGNOS
[6] Hoogenraad TU, 2010, ENCYCLOPEDIA OF MOVEMENT DISORDERS, VOL 3: Q-Z, P335
[7] Paradigm shift in treatment of Wilson's disease: Zinc therapy now treatment of choice
Hoogenraad, TU
[J]. BRAIN & DEVELOPMENT, 2006, 28 (03) : 141 - 146
[8] EFFECTIVE TREATMENT OF WILSONS-DISEASE WITH ORAL ZINC-SULFATE - 2 CASE-REPORTS
HOOGENRAAD, TU
VANDENHAMER, CJA
VANHATTUM, J
[J]. BRITISH MEDICAL JOURNAL, 1984, 289 (6440) : 273 - 276
[9] HOOGENRAAD TU, 1978, LANCET, V2, P1262
[10] ZINC THERAPY AS THE INITIAL TREATMENT FOR WILSONS-DISEASE
HOOGENRAAD, TU
VANHATTUM, J
[J]. ARCHIVES OF NEUROLOGY, 1988, 45 (04) : 373 - 374